Cargando…

Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies

BACKGROUND: Medicare Part D provides insurance coverage for prescription drugs to elderly and disabled consumers. Part D accounted for 24% of prescriptions dispensed by independent pharmacies in the first year of the program (2006). To date, the impact of Part D on independent pharmacies has been ex...

Descripción completa

Detalles Bibliográficos
Autor principal: Carroll, Norman V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437635/
https://www.ncbi.nlm.nih.gov/pubmed/18983206
http://dx.doi.org/10.18553/jmcp.2008.14.8.768
_version_ 1785092574679138304
author Carroll, Norman V.
author_facet Carroll, Norman V.
author_sort Carroll, Norman V.
collection PubMed
description BACKGROUND: Medicare Part D provides insurance coverage for prescription drugs to elderly and disabled consumers. Part D accounted for 24% of prescriptions dispensed by independent pharmacies in the first year of the program (2006). To date, the impact of Part D on independent pharmacies has been explored only in small, qualitative, or non-peer-reviewed studies. OBJECTIVES: To develop preliminary estimates of the impact of Part D on independent pharmacies profitability. METHODS: A financial model was built to examine the impact of Part D on pharmacy profitability. A key input value was the gross margin percentage for Part D; the midpoint of estimates reported in the literature was used as the base-case input value. The remaining model inputs were derived from 2 non-peer-reviewed published sources: (a) the National Community Pharmacist Association (NCPA)'s survey of independent pharmacies, which provided financial data for the year prior to Part D implementation (2005); and (b) IMS Health national market research data, which provided information about changes in prescription drug utilization from 2005 to 2006. Model estimates represented a typical independent pharmacy, defined using mean values for financial measures in 2005 as reported by NCPA. The model examined the impact of Part D on the proportion of prescriptions reimbursed by other sources (private third-party insurance, Medicaid, and cash payments by patients); pharmacies overall prescription gross margin; the number of Part D-induced prescriptions; the number of prescriptions lost to mail-order pharmacies; and net income before taxes. Key values and assumptions were subjected to one-way and probabilistic sensitivity analyses. RESULTS: The model indicated that implementation of Part D resulted in a mean (SD) 22% (4%) decrease in net income before taxes. This change was primarily the result of an absolute 0.7% decline in the gross margin for all prescriptions. The lower overall gross margin resulted from lower reimbursement on Part D prescriptions. In the typical independent community pharmacy, Part D induced an increase in utilization of an estimated 427 prescriptions but 229 prescriptions were lost to mail-order pharmacies. The results were most sensitive to Part D reimbursement rates. Even under the most optimistic assumptions, Part D decreased net income. However, even under the least favorable assumptions, the typical independent pharmacy remained profitable. CONCLUSIONS: Part D reduced the profitability of the typical independent pharmacy by an estimated mean (SD) 22% (4%) in 2006. This reduction resulted primarily from the lower Part D reimbursement rates.
format Online
Article
Text
id pubmed-10437635
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104376352023-08-21 Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies Carroll, Norman V. J Manag Care Pharm Research BACKGROUND: Medicare Part D provides insurance coverage for prescription drugs to elderly and disabled consumers. Part D accounted for 24% of prescriptions dispensed by independent pharmacies in the first year of the program (2006). To date, the impact of Part D on independent pharmacies has been explored only in small, qualitative, or non-peer-reviewed studies. OBJECTIVES: To develop preliminary estimates of the impact of Part D on independent pharmacies profitability. METHODS: A financial model was built to examine the impact of Part D on pharmacy profitability. A key input value was the gross margin percentage for Part D; the midpoint of estimates reported in the literature was used as the base-case input value. The remaining model inputs were derived from 2 non-peer-reviewed published sources: (a) the National Community Pharmacist Association (NCPA)'s survey of independent pharmacies, which provided financial data for the year prior to Part D implementation (2005); and (b) IMS Health national market research data, which provided information about changes in prescription drug utilization from 2005 to 2006. Model estimates represented a typical independent pharmacy, defined using mean values for financial measures in 2005 as reported by NCPA. The model examined the impact of Part D on the proportion of prescriptions reimbursed by other sources (private third-party insurance, Medicaid, and cash payments by patients); pharmacies overall prescription gross margin; the number of Part D-induced prescriptions; the number of prescriptions lost to mail-order pharmacies; and net income before taxes. Key values and assumptions were subjected to one-way and probabilistic sensitivity analyses. RESULTS: The model indicated that implementation of Part D resulted in a mean (SD) 22% (4%) decrease in net income before taxes. This change was primarily the result of an absolute 0.7% decline in the gross margin for all prescriptions. The lower overall gross margin resulted from lower reimbursement on Part D prescriptions. In the typical independent community pharmacy, Part D induced an increase in utilization of an estimated 427 prescriptions but 229 prescriptions were lost to mail-order pharmacies. The results were most sensitive to Part D reimbursement rates. Even under the most optimistic assumptions, Part D decreased net income. However, even under the least favorable assumptions, the typical independent pharmacy remained profitable. CONCLUSIONS: Part D reduced the profitability of the typical independent pharmacy by an estimated mean (SD) 22% (4%) in 2006. This reduction resulted primarily from the lower Part D reimbursement rates. Academy of Managed Care Pharmacy 2008-10 /pmc/articles/PMC10437635/ /pubmed/18983206 http://dx.doi.org/10.18553/jmcp.2008.14.8.768 Text en Copyright © 2008, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
Carroll, Norman V.
Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title_full Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title_fullStr Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title_full_unstemmed Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title_short Estimating the Impact of Medicare Part D on the Profitability of Independent Community Pharmacies
title_sort estimating the impact of medicare part d on the profitability of independent community pharmacies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437635/
https://www.ncbi.nlm.nih.gov/pubmed/18983206
http://dx.doi.org/10.18553/jmcp.2008.14.8.768
work_keys_str_mv AT carrollnormanv estimatingtheimpactofmedicarepartdontheprofitabilityofindependentcommunitypharmacies